Split Creek Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Split Creek Capital's BMY Position: Q3 2026 in Review
Split Creek Capital increased its Bristol-Myers Squibb (BMY) stake by 0.46% in Q3 2026, buying an estimated $1.52K and bringing the position to 5,247 shares worth $327K. The position accounts for 0.31% of the portfolio, ranked #99.
Split Creek Capital first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Split Creek Capital held 5,247 shares of Bristol-Myers Squibb worth $327K as of Q3 2026.
- Split Creek Capital bought 24 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.52K.
- Bristol-Myers Squibb made up 0.31% of Split Creek Capital's portfolio in Q3 2026, its #99 holding.
- Split Creek Capital first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.